Lucid Diagnostics Inc.LUCDNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank43
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-1221.64%
↑ 60% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-3019.97%
Historical baseline
PeriodValueYoY Change
TTM-1221.64%-19.8%
2024-1020.16%+50.2%
2023-2049.05%+85.8%
2022-14385.94%-162.4%
2021-5483.00%-
20200.00%-
20190.00%-
20180.00%-